CDC Admits Covid Boosters Now Only 45.5% Effective | Leronlimab To Treat Long Covid

This video covers two important new topics. First, CDC admits that COVID booster effectiveness against symptomatic infection, plummets to 45.5% after just 3 months. Second, in a new study, Leronlimab, a monoclonal antibody, is showing promise as a Long Covid treatment, but not for the reasons we thought it would. So in this video, I’ll explain the pertinent details of all this new data. We’ll go through my Substack posts together that thoroughly explain each topic. Also, I’ll show you some graphs and images to help you better understand all of this.

Here's are the Substack posts covered in this video:

https://jamescintolo.substack.com/p/cdc-admits-new-bombshell-finding?r=xgj7l&s=w&utm_campaign=post&utm_medium=web

https://jamescintolo.substack.com/p/new-shocking-study-shows-covid-booster?r=xgj7l&s=w&utm_campaign=post&utm_medium=web

REFERENCES:

https://cdc.gov/vaccines/acip/meetings/downloads/slides-2022-04-20/02-COVID-Link-Gelles-508.pdf

https://pubmed.ncbi.nlm.nih.gov/9429890/

https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciac226/6572226?redirectedFrom=fulltext&login=false

LETS CONNECT:

https://twitter.com/healthbyjames

https://www.facebook.com/james.cintolo

https://www.facebook.com/healthbyjames

https://jamescintolo.substack.com

https://www.patreon.com/jamescintolo

https://www.buymeacoffee.com/healthbyjames

https://www.instagram.com/healthbyjamesc

*THIS VIDEO IS NOT MEDICAL ADVICE AND SHOULD NOT BE USED AS SUCH. CONSULT YOUR PHYSICIAN IF YOU HAVE MEDICAL NEEDS/QUESTIONS THAT NEED TO BE ADDRESSED